Showing results (571-580 of 631) with videos related to
Sort By:
Pageof 64
Rheumatology (Oxford, England)|September 30, 2024
Long-term retention rate, adverse event temporal patterns and rescue treatment strategies of mycophenolate mofetil in systemic sclerosis: insights from real-lifeEnrico De Lorenzis, Gerlando Natalello, Greta Pellegrino, et al.Blood Purification|July 14, 2020
Prevalence, Characteristics, Risk Factors, and Outcomes of Invasively Ventilated COVID-19 Patients with Acute Kidney Injury and Renal Replacement TherapyEvgeny V Fominskiy, Anna Mara Scandroglio, Giacomo Monti, et al.Leukemia|May 28, 2025
Cluster analysis reveals the clinical spectrum of Erdheim-Chester diseaseMichelangelo Tesi, Francesco Pegoraro, Francesco Peyronel, et al.Nature Genetics|May 21, 2013
A functional variant in the CFI gene confers a high risk of age-related macular degenerationJohannes P H van de Ven, Sara C Nilsson, Perciliz L Tan, et al.Arthritis & Rheumatology (Hoboken, N.J.)|September 22, 2025
Comparative Efficacy and Safety of Anakinra and Canakinumab in Patients With VEXAS Syndrome: An International Multicenter StudyTali Eviatar, Dafne Capelusnik, Corrado Campochiaro, et al.Rheumatology (Oxford, England)|February 13, 2021
The clinical phenotype of systemic sclerosis patients with anti-PM/Scl antibodies: results from the EUSTAR cohortMaria-Grazia Lazzaroni, Emiliano Marasco, Corrado Campochiaro, et al.Annals of the Rheumatic Diseases|May 15, 2023
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patientsSara Monti, Alessandra Milanesi, Catherine Klersy, et al.Blood|June 2, 2021
Oncogene-induced maladaptive activation of trained immunity in the pathogenesis and treatment of Erdheim-Chester diseaseRaffaella Molteni, Riccardo Biavasco, Davide Stefanoni, et al.British Journal of Haematology|November 13, 2024
Methodology and clinical utility of longitudinal UBA1 tracking in VEXAS syndromeCarmelo Gurnari, Elisa Galossi, Eleonora Lumia, et al.RMD Open|June 16, 2023
Inflammatory rheumatic diseases with onset after SARS-CoV-2 infection or COVID-19 vaccination: a report of 267 cases from the COVID-19 and ASD groupFrancesco Ursini, Piero Ruscitti, Olga Addimanda, et al.Pageof 64